abstract |
The present invention relates to the compounds of the formula (I): (see Formula) wherein R1, R2, R3, and A are defined herein. The present invention also provides pharmaceutical compositions comprising a compound of the formula (I), as well as the use of these compounds as androgen receptor antagonists for the treatment of diseases and conditions mediated by the androgen receptor, such as prostate cancer. |